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Abstract
Introduction It is recognized that administration of insulin with glucose decreases catabolic response
in sepsis. The aim of the present study was to compare the effects of two levels of insulinaemia on
glucose metabolism and energy expenditure in septic patients and volunteers.
Methods Glucose uptake, oxidation and storage, and energy expenditure were measured, using
indirect calorimetry, in 20 stable septic patients and 10 volunteers in a two-step hyperinsulinaemic
(serum insulin levels 250 and 1250 mIU/l), euglycaemic (blood glucose concentration 5 mmol/l) clamp.
Differences between steps of the clamp (from serum insulin 1250 to 250 mIU/l) for all parameters were
calculated for each individual, and compared between septic patients and volunteers using the
Wilcoxon nonpaired test.
Results Differences in glucose uptake and storage were significantly less in septic patients. The
differences in glucose oxidation between the groups were not statistically significant. Baseline energy
expenditure was significantly higher in septic patients, and there was no significant increase in either
step of the clamp in this group; when comparing the two groups, the differences between steps were
significantly greater in volunteers.
Conclusion A hyperdynamic state of sepsis leads to a decrease in glucose uptake and storage in
comparison with healthy volunteers. An increase in insulinaemia leads to an increase in all parameters
of glucose metabolism, but the increases in glucose uptake and storage are significantly lower in septic
patients. A high level of insulinaemia in sepsis increases glucose uptake and oxidation significantly, but
not energy expenditure, in comparison with volunteers.
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Introduction
Many of the host responses to sepsis are similar to those seen
after major injury, with increased energy expenditure (EE),
enhanced protein catabolism [1-3], increased use of lipids as
oxidative fuel, and impaired glucose metabolism [4]. Septic
patients are insulin resistant; they have increased hepatic glu-
cose production, reduced peripheral glucose utilization and
increased lipolysis [5].
The causes of the metabolic changes that accompany sepsis
are not clear. It seems that neither stress hormones (glucagon,
catecholamines, corticosteroids, growth hormone) nor high
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levels of gluconeogenic precursors (lactate, alanine, glycerol)
are the main cause of this syndrome [6,7]. Endotoxin or the
cytokines tumour necrosis factor-α and interleukin-1 can
induce a state of insulin resistance when they are infused con-
tinuously. It is possible that, because of this insulin resistance,
the cytokines may redistribute glucose away from skeletal
muscle to ensure adequate nutrient supply to inflammatory
cells [7-9].
The postinjury metabolic changes characterized by insulin
resistance are severe but fully reversible, and high doses of
insulin together with glucose can have an important protein
sparing effect in critically ill patients [10-12]. After surgery
dogs have elevated hepatic glucose production, which can be
suppressed by exogenous insulin. By contrast, postoperative
sepsis in dogs is associated with more marked elevation in
gluconeogenesis, with low response to exogenous insulin
[13]. Dahn and coworkers [14] found that patients with a com-
bination of trauma and sepsis had a hepatic glucose produc-
tion almost six times higher (with absolute values of 16.6 µmol/
kg per min) than that in patients with comparable trauma alone.
In these traumatized septic patients, gluconeogenesis was
responsible for 93% of hepatic glucose production, as com-
pared with 87% in the injured patients and 46% in healthy indi-
viduals. In septic cancer bearing patients, resistance to
insulin's effect on plasma free fatty acid turnover (an index of
lipolysis) is more pronounced than resistance to its inhibiting
effect on endogenous glucose production or its stimulating
effect on tissue glucose uptake [15]. The extent of injury suf-
fered by patients based on the injury severity score correlated
only with their EE, but not with hepatic glucose production,
glycaemia, glucose oxidation, glucose turnover, or nonoxida-
tive glucose utilization [12]. Shaw and Wolfe [2] also found no
correlation between injury severity score and glucose produc-
tion in 33 critically ill patients suffering from blunt trauma.
Thus, sepsis combined with trauma is associated with more
marked insulin resistance and disturbance of glucose metabo-
lism than is trauma alone [13,14]. It is unclear whether this is
a simple additive effect on glucose metabolism or whether
there is some interaction, with trauma enhancing the effect of
sepsis. Thus, it would be worthwhile to study septic patients
who do not have associated trauma. We therefore conducted
the present study to evaluate the action of insulin on glucose
metabolism and associated thermogenesis in sepsis uncom-
plicated by trauma. Specifically, we studed the effect of two
levels of insulinaemia (250 mIU/l in step 1 and 1250 mIU/l in
step 2) in the presence of a euglycaemic clamp on glucose
metabolism (glucose uptake, oxidation, storage) and EE in
septic patients.
Methods
Twenty septic nondiabetic patients were studied over a 2.5-
year period (Table 1). The patients were in a hyperdynamic
state of sepsis 3–7 days following admission to the intensive
care unit, after their acute state had been stabilized and
vasoactive drugs stopped. All of the patients underwent
mechanical ventilation and required parenteral nutrition (all-in-
one system), together with low doses of enteral nutrition. All
required a continuous intravenous infusion of insulin to main-
tain their blood glucose concentration below 10 mmol/l.
Severity of illness was assessed in each patient immediately
before the study using the Acute Physiology and Chronic
Health Evaluation II scoring system [16,17], and empirical cri-
teria for the diagnosis of sepsis [18-20] were used. For inclu-
sion in the study, each patient was required to satisfy at least
four of the criteria presented in Table 2, together with a suspi-
cion of infection. The causes of sepsis at admission were bron-
chopneumonia (n = 5), cholangitis (n = 2), urosepsis (n = 3),
catheter-related sepsis (n = 3), and sepsis as a complication
of treatment for acute haemoblastosis, mostly after bone mar-
row transplantation and without a clear focus (n = 7). These
criteria were applied because the method used in the study to
measure glucose parameters and EE (indirect calorimentry)
requires patients in a hyperdynamic phase of sepsis to be
relatively stable, both haemodynamically and in terms of respi-
ratory status, and not receiving vasoactive treatment. Stability
during the study was defined as not requiring a change in ven-
tilatory setting, no need for large volumes of fluids and/or
vasoactive drug treatment, and no change of body tempera-
ture (± 1°C). The main reasons for excluding a patient from the
study were haemodynamic instability and changes in pH,
which can invalidate the indirect calorimetry method. Inclusion
and exclusion criteria for the patients are summarized in Table
2. Also included was a control group of healthy volunteers,
who were not obese and had no family history of diabetes.
The study was conducted in the medical intensive care unit at
Charles University Hospital, Plzen, Czech Republic. The study
protocol was approved by the local university ethical commit-
tee, and written informed consent was obtained from volun-
teers and the patient's family before they were entered into the
study. All investigations were conducted between 07:00 and
Table 1
Cha racteristics of the septic patients
Characteristic Details
Number of patients 20
Gram-positive/Gram-negative sepsis 16/4
Duration from admission to start of study (days) 3.8 (2.5–5.4)
APACHE II score 20.2 (18.3–22.4)
Parenteral nutrition (kcal/kg per 24 hours) 20.2 (16.3–24.2)
Enteral nutrition (kcal/kg per 24 hours) 6.3 (3.2–10.1)
Insulin requirement/24 hours (IU/24 hours) 56 (48–74)
Values are expressed as number or as median (interquartile range). 
APACHE, Achute Physiology and Chronic Health Evaluation.Available online http://ccforum.com/content/8/4/R213
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13:00 hours. Patients did not receive any nutritional support or
intravenous insulin for at least 9 hours before the study. Crys-
talloids were infused as indicated clinically, together with
established drug treatments. A multilumen central venous
catheter and arterial catheter, already positioned in the
patients, were used for infusion of all test substances and
blood sampling, respectively. Each patient's height was meas-
ured using a tape measure with the patient in the supine posi-
tion. Weight was measured using a bed weighing system
(Datex II; Datex-Ohmeda Division Instrumentarium Corp., Hel-
sinki, Finland) and body mass index was calculated.
Volunteers were recruited from among the hospital staff and
their relatives. They were advised to consume a weight-main-
taining diet containing at least 200 g/day of carbohydrates for
3 days before the study. None was receiving any medication.
Arterialized venous blood was sampled using a cannula
inserted retrogradely into a dorsal hand vein, with the hand
resting in a warm air box (55–60°C) to 'arterialize' the blood
[21,22]. A second cannula was placed in an antecubital vein
for infusion of all test substances.
The clamp technique was as follows. A two-step insulin clamp,
each step being 120 min in duration, was performed using a
primed continuous insulin infusion (Humulin R; Ely Lilly, Pen-
sylvania, Penn. USA). In step 1 insulin was infused, using a
syringe pump (Braun, Melsungen AG, Melsungen, Germany),
to achieve a steady serum insulin level (IRI) of 250 mIU/l. In the
second step insulin was infused at a fivefold higher rate to
achieve an IRI of 1250 mIU/l. During both steps, 20% glucose
(Infusia Horastev, Horastev, Czech Republic) was infused at a
variable rate using an infusion pump (Braun) to maintain the
arterial blood glucose concentration at 5 mmol/l (i.e. a glucose
clamp) [23]. During the clamp, blood glucose concentration
was measured every 5 min (HemoCue glucose analyser;
HemoCue Ltd, Ängelholm, Sweden) and the rate of glucose
infusion adjusted to maintain the blood glucose concentration
at 5 mmol/l. During the steady state periods of each step in the
clamp, the blood glucose concentration was maintained within
5% of the target value (i.e. 5 mmol/l), which ensured the pres-
ence of glycaemic stability during periods when insulin sensi-
tivity was being assessed.
Throughout the baseline period and for the last 40 min of each
step of the clamp (i.e. steady state periods), oxygen consump-
tion (VO2) and carbon dioxide production (VCO2) were meas-
ured using indirect calorimetry (Deltatrac II; Datex-Ohmeda
Division Instrumentarium Corp., Helsinki Finland), in canopy
mode for healthy volunteers and in respiratory mode for
mechanically ventilated patients. EE and respiratory quotient
(RQ) were calculated (RQ = VCO2/VO2). Protein oxidation
was calculated from urinary urea excretion rate corrected for
changes in the body urea pool using standard formula.
Amounts of VCO2  and VO2  involved in protein oxidation
(VCO2prot and VO2prot) were then subtracted from the total
values measured using indirect calorimetry to yield the nonpro-
tein RQ (i.e. nonprotein VCO2/nonprotein VO2). Peripheral
glucose utilization (mg/kg per min) was calculated as a rate of
exogenous glucose infused in each steady state period of the
clamp, and the mean for each step was calculated [23]. Whole
body glucose oxidation (mg/kg per min) was calculated from
the nonprotein RQ. Nonoxidative glucose disposal, which
equals glucose storage in healthy individuals, was calculated
as the difference between glucose utilization and oxidation.
Blood samples for substances other than glucose were taken
at the end of the baseline period and twice (at 5 and 15 min)
in each steady state period, and means were calculated. C-
peptide and 'free' serum insulin (IRI) were determined by radi-
oimmunoassay (Serono Diagnostics, Milan, Italy), triglycerides
and lactate using the enzymatic method (analyzer Hitachi 717;
ROCH Diagnostics, Manheim, Germany), free fatty acids
using the photometry method (Hitachi 717), and alanine by the
ion exchange chromatography method using an analyser
(Mikrotechna, Praha, Czech Republic). Blood gases were
measured using a blood gas analyzer (ABL 520™ Radiometer,
Copenhagen, Denmark), urea in urine by an enzymatic method
using an analyzer (Hitachi 717), serum potassium using a
flame photometer (Corning, London, UK) and osmolality using
an osmometer (Knauer, Berlin, Germany).
Table 2
Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Temperature (°C) >38.5 or <36 FiO2 >0.7
White cell count (×109/l) >12 or <3.5 Mean blood pressure (mmHg) <75
Mean CI (l/min per m2) and SVR (dynes/s·m-5) CI > 4.5, SVR (dynes/s·m-5) <800 Mean CI (l/min per m2)< 3
Platelets count (×109/l) <100 Changes in serum buffer base > 10% in the past 12 hours
Blood cultures Positive Increasing trend in serum lactate level in the past 12 hours
Clinical evidence of sepsis Positive Haemofiltration or haemodialysis
CI, cardiac index; FiO2 = partial oxygen pressure in inspired air; SVR, systemic vascular resistance.Critical Care    August 2004  Vol 8 No 4    Rusavy et al.
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Statistical analysis
Data are expressed as mean ± standard deviation. Statistical
analyses were conducted to determine whether distributions
were normal, and paired t-tests were used for within-group
and Wicoxon's test was used for between-group compari-
sons. Because of the relatively small numbers of measure-
ments, in which the type of distribution cannot be determined
with full certainty, we opted not to assume normality of the dis-
tributions. Therefore, nonparametric tests were used for the
evaluation (Wilcoxon's test: paired for within groups and non-
paired for between groups). The distribution of values is
described by medians and interquartile ranges. For easier
interpretation of the comparison of the effects of insulin in sep-
tic patients and volunteers, for each parameter we opted to
calculate the differences between steps 2 and 1, and between
step 1 and baseline for each individual, and we tested the dif-
ferences in these calculated values between the groups.
Results
All patients and volunteers remained stable and completed the
study. A comparison of septic patients and volunteers at base-
line, before the clamp protocol, is provided in Table 3. Meas-
ured insulin concentrations in plasma (IRI) were significantly
higher in septic patients than in volunteers at baseline. In step
1 of the clamp the measured IRI (median [interquartile range])
was 197.5 (184.6–225.8) mIU/l in septic patients and in vol-
unteers it was 212.4 (182.3–226.2) mIU/l. In step 2 of the
clamp the measured IRI in septic patients was 1941.4
(1894.7–2356.8) mIU/l and in volunteers it was 2200.2
(1886.3–2451.6) mIU/l. The difference between groups in
measured IRI was not statistically significant at either step.
Findings regarding glucose metabolism in septic patients and
volunteers are shown in Tables 4,5,6. Glucose uptake (Table
4) increased significantly within both groups; however, in the
comparison of differences (step 1 minus step 2) between sep-
tic patients and volunteers it increased significantly more in
volunteers. Similar results were obtained for glucose storage
(Table 6). Glucose oxidation increased within both groups, but
comparison of differences between groups was not
statistically significant. The EE findings in septic patients and
volunteers are shown in Table 7. In septic patients the differ-
ences between baseline, step 1 and step 2 were not statisti-
cally significant. In volunteers there was a significant increase
in EE between baseline and step 1, and between step 1 and
step 2. EE at baseline was significantly greater in septic
patients than in volunteers. The differences between septic
patients and volunteers in step 1 minus baseline, and step 2
minus step 1 were also statistically significant; specifically, the
increase in EE was lower in septic patients in step 1 and in
step 2. The RQ findings are presented in Table 8. RQ
increased in both groups, and the increases were statistically
significant, but findings in the comparison between groups
were not significant.
At step 1 plasma alanine did not change in comparison with
baseline in septic patients (411.2 [320.3–511.6] and 398.3
[352.4–489.5] µmol/l, respectively), but at step 2 it decreased
significantly (252.4 [186.7–276.7] µmol/l; P < 0.01). For the
statistical evaluation the Wilcoxon paired test was used. There
was a decreasing trend in free fatty acids in septic patients
during the study (0.37 [0.22–0.57] µmol/l at baseline, 0.26
[0.19–0.44] µmol/l at step 1, and 0.24 [0.18–0.38] µmol/l at
Table 3
Comparison of septic patients and volunteers at baseline
Parameter Septic patients Volunteers Wilcoxon test
Number of patients 20 10 -
BMI (kg/m2) 26 (24.6–27.8) 22 (21–26.6) NS
Age (years) 65 (52–68) 39 (22–61) P < 0.05
Energy expenditure (kcal/24 hours) 2116 (1880–2455) 1657 (1513–1826) P < 0.01
Respiratory quotient 0.79 (0.77–0.85) 0.83 (0.82–0.86) NS
Glycaemia (mmol/l) 6.2 (5.25–8.21) 4.6 (4.4–5.2) P < 0.001
Insulinaemia (mIU/l) 37.2 (28.3–75.1) 12.7 (9.3–28.4) P < 0.05
HbA1c (%) 4.9 (4.5–5.1) 4.8 (4.6–5.2) NS
Lactate (mmol/l) 1.1(1.0–1.3) 0.9 (0.8–1.2) NS
Buffer base (mmol/l) 23.6 (22.7–24.1) 24.1 (22.1–24.2) NS
Potassium (mmol/l) 4.3 (4.1–4.6) 3.9 (3.8–4.3) NS
Triglycerides (mmol/l) 2.15 (2.00–2.73) 1.91 (1.82–2.54) NS
C-peptide (nmol/l) 0.9 (0.6–1.4) 1.1 (0.7–1.9) NS
Values are expressed as number or as median (interquartile range). BMI, body mass index; NS, not significant.Available online http://ccforum.com/content/8/4/R213
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Table 4
Glucose uptake in septic patients and volunteers
Parameter Septic patients Volunteers Significance (between groups)1
Glucose uptake in step 1 3.61 (2.31–5.58) 11.0 (9.74–12.85) -
Glucose uptake in step 2 6.4 (5.25–8.21) 17.2 (14.05–19.20) -
Significance (within groups)2: step 1 versus step 2 P < 0.001 P < 0.01 -
Difference between step 2 and step 1 2.5 (0.93, 4.47) 5.3 (4.14, 6.40) P < 0.01
Values are expressed as median (interquartile range). 1By Wilcoxon's nonpaired test. 2By Wilcoxon's paired test.
Table 5
Glucose oxidation in septic patients and volunteers
Parameter Septic patients Volunteers Significance (between groups)1
Glucose oxidation in step 1 2.82 (1.66–4.02) 3.4 (3.00–4.00) -
Glucose oxidation in step 2 3.73 (2.73–4.97) 4.5 (4.30–5.65) -
Significance (within groups)2: step 1 versus step 2 P < 0.01 P < 0.01 -
Difference between step 2 and step 1 0.71 (-0.26–0.72) 1.22 (0.30–1.75) NS
Values are expressed as median (interquartile range). 1By Wilcoxon's nonpaired test. 2By Wilcoxon's paired test.
Table 6
Glucose storage in septic patients and volunteers
Parameter Septic patients Volunteers Significance (between groups)1
Glucose storage in step 1 0.4 (-0.4 to +3.19) 7.6 (5.80–9.50) -
Glucose storage in step 2 2.3 (0.92–4.16) 11.6 (9.70–13.60) -
Significance (within groups)2: step 1 versus step 2 P < 0.01 P < 0.01 -
Difference between step 2 and step 1 1.51 (0.24–2.69) 4.0 (2.95–5.30) P < 0.01
Values are expressed as median (interquartile range). 1By Wilcoxon's nonpaired test. 2By Wilcoxon's paired test.
Table 7
Energy expenditure in septic patients and volunteers
Parameter Septic patients Volunteers Significance (between groups)1
EE at baseline 2116 (1880–2455) 1657 (1513–1826) ++
EE in step 1 2213 (1914–2475) 1850 (1731–2079) -
Significance (within groups)2: baseline versus step 1 NS P < 0.01 -
Difference between step 1 and baseline 35.00 (-110 to +260) 217.75 (101.58–309.08) +
EE in step 2 2179 (1911–2179) 2019 (1907–2230) -
Significance (within groups)2: step 1 versus step 2 NS P < 0.05 -
Difference between step 2 and step 1 -12 (-61 to +153) 154 (-21 to +288) -
Values are expressed as median (interquartile range). 1By Wilcoxon's nonpaired test. 2By Wilcoxon's paired test. EE, energy expenditure; NS, not 
significant; ++, p < 0.05; +, p < 0.01.Critical Care    August 2004  Vol 8 No 4    Rusavy et al.
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step 2), although the differences were not statistically
significant.
In comparison with findings at baseline, potassium, lactate,
urea, base excess and osmolality in both steps of the clamp
were not statistically different. In volunteers all results were
normal; only free fatty acids exhibited a trend similar to that in
septic patients, but this was not statistically significant.
Discussion
Many trials have attempted to manipulate the metabolic
response to critical illness. Van den Berghe and coworkers
[24] normalized the blood glucose level (4.4–6.1 mmol/l) in
intensive care patients by using insulin and glucose. In com-
parison with conventionally treated septic patients, this
method decreased mortality (4.6% versus 8.0%), decreased
the incidence of multiple organ failure with a proven septic
focus, and decreased renal dysfunction and need for red cell
transfusion. In another study of diabetic patients who had suf-
fered a myocardial infarction [25], intensive insulin treatment
was performed to achieve a blood glucose concentration
below 11 mmol/l. This resulted in a significant improvement in
patient outcomes, including later mortality. These studies were
limited to patients undergoing cardiac surgery or who had suf-
fered acute myocardial infarction, and therefore the results
cannot be extrapolated without further study to patients with
other types of critical illness. It is impossible to differentiate
between the direct effects of infused insulin and the effects of
preventing hyperglycaemia. Insulin might play a role that is
independent of its effect on glycaemia. Insulin has been shown
to inhibit tumour necrosis factor-α [26], increase glucose
uptake, and produce a significant protein anabolic effect [27].
Glucose uptake
In healthy people, during the steady state period of a hyperin-
sulinaemic glucose clamp, the rate of exogenous infusion of
glucose (corrected for changes in body extracellular glucose
space and urinary glucose excretion) is equal to the rate of glu-
cose utilization because endogenous glucose production is
suppressed by hyperinsulinaemia [23]. The suppressive
effects of both insulin and glucose on endogenous glucose
production are altered in critically ill patients. This would lead
to an underestimation of the rate of total glucose utilization of
up to 3 mg/kg per min [28,29]. Another study conducted in
septic patients [30] indicated that hepatic glucose production
would be suppressed completely at a serum insulin of 240
mIU/l. Nevertheless, because the glucose uptake was mark-
edly lower in septic patients than in volunteers in the present
study, it is clear that the insulin resistance of sepsis hindered
glucose utilization. The increased glucose uptake in extreme
nonphysiological levels of insulinaemia in our study suggests
that insulin resistance may be overcome, at least partially, in
sepsis. We can conclude that an increase in insulinaemia in
sepsis further increases glucose utilization.
Glucose oxidation and storage
In some human studies glucose oxidation was unaffected by
sepsis [15] and in others it was decreased [2]. In our study
glucose oxidation decreased by a smaller extent than glucose
utilization in septic patients in comparison with volunteers, but
this was not statistically signficant. If glucose oxidation is pre-
sented as a percentage of glucose uptake, then in the present
study it was 74% at step 1 and 57% at step 2 in septic
patients, and in volunteers it was only 32% and 29%, respec-
tively. There is no marked deficiency in the ability to oxidize
glucose during critical illness [31], but glucose storage is
markedly limited in sepsis [32]. We found that there was lim-
ited glucose storage at both steps of the clamp in septic
patients in comparison with volunteers, which indicates that
insulin resistance in sepsis affects glucose storage to a
greater degree than it affects glucose oxidation Similar results
were also presented by Saeed and coworkers [32]. We can
conclude that glucose oxidation, and to some extent glucose
storage, can be increased in septic patients by increasing the
Table 8
Respiratory quotient in septic patients and volunteers
Parameter Septic patients Volunteers Significance (between groups)1
RQ at baseline 0.79 (0.77–0.85) 0.83 (0.82–0.86) NS
RQ in step 1 0.91 (0.85–0.97) 0.90 (0.85–0.96) -
Significance (within groups)2: baseline versus step 1 P < 0.01 P < 0.01 -
Difference between step 1 and baseline 0.08 (0.04–0.17) 0.09 (0.05–0.11) NS
RQ in step 2 0.97 (0.89–1.01) 0.97 (0.96–0.98)
Significance (within groups)2: step 1 versus step 2 P < 0.05 P < 0.01
Difference between step 2 and step 1 0.03 (0.00–0.08) 0.03 (0.02–0.08) NS
Values are expressed as median (interquartile range). 1By Wilcoxon's nonpaired test. 2By Wilcoxon's paired test. RQ, respiratory quotient; NS, not 
significant.Available online http://ccforum.com/content/8/4/R213
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insulin dosage, but It appears that the deficiency in glucose
storage cannot be attenuated to any significant degree by a
high insulin dosage.
Energy expenditure
The indirect calorimetry measurements not only provide infor-
mation on substrate oxidation but also allow whole body EE to
be estimated. In multiple organ failure there is no relationship
between severity of illness and EE, and so EE cannot reliably
be predicted and must be measured using indirect calorimetry
[33]. Measurement of EE in ventilated patients with multiple
organ failure have consistently yielded a wide range of values
(50–200% of the estimated value, calculated on the basis of
age, sex, height and weight) [33]. In the present study the
baseline EE of the volunteers and septic patients were meas-
ured and are shown in Tables 3 and 5. It is clear that the septic
patients had elevated baseline values, along with greater vari-
ation between individual patients, than did the volunteers. Dur-
ing the clamp, EE increased only marginally in septic patients
by 4.6% in step 1 and by 6.3% in step 2, as compared with
EE at baseline. This contrasted with a significant increase in
EE in volunteers by 13.7% in step 1 and by 23.8% in step 2,
as compared with EE at baseline. In volunteers insulin stimula-
tion of glucose metabolism is accompanied by an increase in
EE (thermogenic effect of glucose). In patients with multiple
organ failure, such an increase in EE does not occur [3].
Brandi reported similar results from patients after major
uncomplicated surgery and severely ill patients suffering from
blunt trauma [1]. In the present study relatively stable EE was
maintained in septic patients despite increased glucose utili-
zation and oxidation. It is possible that the increased energy
costs associated with increased glucose utilization were offset
by the simultaneous decrease in other energy consuming met-
abolic processes (e.g. gluconeogenesis, protein catabolism).
Other metabolites
The decreasing levels of alanine during step 2 of the clamp in
septic patients suggest a possible decrease in protein catab-
olism. However, there was no significant decrease in free fatty
acids in septic patients, indicating an inability of these insulin
concentrations to overcome the insulin resistance in adipose
tissue [5].
Limitations of the study
The volunteers were younger, and had lower fasting glycaemia
and EE. Increased age decreases insulin sensitivity, and the
older age of the septic patients could have influenced our find-
ings to some extent. Measured insulin concentrations in
plasma were significantly higher in septic patients than in vol-
unteers at baseline (Table 2). In both steps of the clamp, the
measured insulinaemia was lower in septic patients but the dif-
ference was not statistically significant. These differences
between insulinaemias were small and could be due to labora-
tory errors that may occur when measuring extreme insulin
concentrations, and probably do not influence the results. Esti-
mation of substrate metabolism from urine sampling and indi-
rect calorimetry has its limitations [34]. We assumed that any
error is the same for septic patients as for volunteers, because
the former were stable with regard to acid-base balance and
were receiving nutritional support. Despite the fact that the
Deltatrac monitor has been validated for indirect calorimetry
measurements in intensive care units, calculation of carbohy-
drate and fat utilization on the basis of nonprotein RQ (i.e. with-
out the use of isotopes) can lead to errors if the rates of
gluconeogenesis and ketogenesis are changing [34].
Conclusion
The hyperdynamic state of sepsis, in comparison with healthy
volunteers, leads to decreases in glucose uptake, oxidation
and storage. During the hyperinsulinaemic, euglycaemic
clamp experiments, an increase in insulinaemia significantly
increased glucose uptake, oxidation and storage in both
groups. The lower glucose uptake in septic patients was
mainly due to an impairment in glucose storage. Increasing lev-
els of insulinaemia in patients with sepsis increased glucose
uptake significantly, but not EE, in comparison with volunteers.
Further studies are needed to establish whether insulin may
have a positive effect in sepsis by increasing the rate of glu-
cose oxidation with simultaneous reduction in protein catabo-
lism [35].
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